Alto Neuroscience Inc

ANRONYSE · USD
22.00USD-0.20 (-0.93%)
2210

Alto Neuroscience Inc (ANRO) Straddle

ANRO straddle scan found 17 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 64.0%.

Read more

Trading a ANRO straddle lets you take a pure volatility position on Alto Neuroscience Inc without committing to a direction. Alto Neuroscience Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ANRO straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on ANRO profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Alto Neuroscience Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ANRO straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to treat patients with MDD; and ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor for the treatment of cognitive impairment associated with schizophrenia. It also develops ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist to treat patients with MDD and higher levels of anhedonia, and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor for the treatment of MDD.

In addition, the company develops novel pharmacodynamically synergistic combinations and an AI-enabled biomarker platform that combine sources of information on patients brain activity and behavior to identify patients to respond to novel product candidates. Alto Neuroscience, Inc. was incorporated in 2019 and is based in Los Altos, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the ANRO straddle is the cleanest expression of that view. Our scanner prices every ANRO straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ANRO straddle into a catalyst or short a ANRO straddle to harvest decay, the options straddle setups that matter are all in one place.

Jan 15, 202730.00$9.239136%64.0%$39.23$20.780
Jan 15, 202725.00$6.509136%63.8%$31.50$18.504
Apr 16, 202730.00$12.4318236%62.2%$42.43$17.5810
Apr 16, 202735.00$16.1018236%62.1%$51.10$18.900
Apr 16, 202740.00$20.7318236%60.6%$60.73$19.280
Apr 16, 202725.00$10.0318236%59.1%$35.03$14.9810
Dec 18, 202622.50$5.406336%57.7%$27.90$17.100
Apr 16, 202722.50$9.3518236%55.7%$31.85$13.150
Dec 18, 202625.00$6.856336%54.8%$31.85$18.150
Jan 15, 202722.50$7.459136%51.3%$29.95$15.0534

As of October 22, 2026

Find the right straddle before volatility moves

Track ANRO straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial